Growth Opportunity Mid-sized life science RWE and HEOR services firm with 25-50M revenue and 201-500 employees presents a target for expanding payer engagement, pricing strategy, and market access offerings into larger pharma partnerships and strategic collaborations.

Leadership Hire Recent appointment of Tim Wright as Executive Vice President, Access and Pricing signals a strategic emphasis on access, reimbursement strategies, and pricing analytics—a door for sales to align with enhanced pricing and payer access capabilities.

Data Analytics Launch of US Market Access data analytics and ongoing RWE/HEOR services indicate opportunities to upsell integrated data-driven market access solutions to firms seeking evidence-informed payer decisions and regulatory support.

Partnership Momentum Strategic collaborations and recent news partnerships, such as with Evidence Base, demonstrate a track record of co-developing thought leadership and evidence programs that can be leveraged to win co-sponsored or joint-research engagements.

Expansion Readiness Active participation in webinars, conferences, and cross-border real-world evidence initiatives across Europe and the US suggests readiness to scale services to global life sciences clients seeking international HEOR and HTA support.